Home » Topics » BioWorld Science

BioWorld Science
RSS

U.S. orphan designation granted to Alnylam Pharmaceuticals siRNA therapy for amyloidosis

June 4, 2018

Fully human antibody cocktail shows postexposure protection against lethal Ebola virus in primates

June 4, 2018

Vanderbilt University synthesizes new mGlu4 receptor positive allosteric modulators

June 4, 2018

Bruton tyrosine kinase inhibitors divulged by Daewoong Pharmaceutical

June 4, 2018

Kyushu University patents EGFR inhibitors

June 4, 2018

Neural stem cells delivering chimeric orthopoxvirus created to treat ovarian cancer

June 4, 2018

Aimovig receives positive CHMP opinion for the prevention of migraine

June 4, 2018

First clinical data for the IDH1/2 inhibitor AG-881 in solid tumors

June 4, 2018

Exondys receives negative CHMP opinion

June 4, 2018

Rxulti receives positive opinion in Europe for the treatment of schizophrenia in adults

June 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...